ReviewInternational journal of molecular sciences2018

Pazopanib, Cabozantinib, and Vandetanib in the Treatment of Progressive Medullary Thyroid Cancer with a Special Focus on the Adverse Effects on Hypertension.

Rikke Vilsbøll Milling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.